This is the first study to report, in detail, patterns of resource use and costs associated with real-world administration of denosumab and zoledronic acid.
Ralph P. Insinga, PhD
Advertisement
Articles by Ralph P. Insinga, PhD
Advertisement
Latest Updated Articles
- Administration Costs of Denosumab and Zoledronic Acid for Postmenopausal Osteoporosis
Published: June 21st 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Bacteria and Fungi in the Mouth Found to Drive Pancreatic Cancer Risk
2
FDA Approves Lurbinectedin Combination Regimen in Extensive-Stage SCLC
3
Pfizer Agrees to Lower Certain Drug Prices in US, Aligning With ‘Most-Favored Nation’ Plan
4
Metabolic Bariatric Surgery Outperforms GLP-1s in Weight Loss With Lower Long-Term Costs
5
